Try our beta test site
6 studies found for:    IMCgp100
Show Display Options
Rank Status Study
1 Completed Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Drug: IMCgp100
2 Not yet recruiting IMCgp100-401 Rollover Study
Condition: Malignant Melanoma
Intervention: Drug: IMCgp100
3 Completed IMCgp100 in Advanced Unresectable Melanoma
Conditions: Melanoma;   Advanced Disease;   Unresectable
Intervention: Drug: IMCgp100 injection
4 Not yet recruiting Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Biological: IMCgp100;   Drug: Dacarbazine;   Biological: Ipilimumab;   Biological: Pembrolizumab
5 Recruiting A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: IMCgp100
6 Recruiting Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma
Condition: Malignant Melanoma
Interventions: Drug: IMCgp100;   Drug: durvalumab;   Drug: tremelimumab

Study has passed its completion date and status has not been verified in more than two years.